Spontaneous rectus sheath hematoma in a patient treated with apixaban.

Intractable Rare Dis Res

Departmant of Cardiology, Aksaray State Hospital, Aksaray, Turkey.

Published: February 2016

Apixaban, a non-vitamin K antagonist oral anticoagulants, is a Factor Xa inhibitor that is prescribed for the treatment of non valvular atrial fibrillation. Rectus sheath hematoma is a rare but significant complication of oral anticoagulant treatment. The important causes of rectus sheath hematoma include treatment with anticoagulants, hematologic diseases, trauma, intense physical activity, coughing, sneezing and pregnancy. In this report, we describe case of a 71-year-old woman undergoing apixaban treatment for non valvular atrial fibrillation who presented with spontaneous rectus sheath hematoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761585PMC
http://dx.doi.org/10.5582/irdr.2015.01039DOI Listing

Publication Analysis

Top Keywords

rectus sheath
16
sheath hematoma
16
spontaneous rectus
8
treatment valvular
8
valvular atrial
8
atrial fibrillation
8
sheath
4
hematoma
4
hematoma patient
4
patient treated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!